These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2251843)

  • 21. Calcitonin therapy for bone disease and hypercalcemia.
    Avioli LV
    Arch Intern Med; 1982 Nov; 142(12):2076-9. PubMed ID: 7138154
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of osteoporosis with calcitonin.
    Wallach S; Aloia J; Cohn S
    Semin Drug Treat; 1972; 2(1):21-5. PubMed ID: 5065516
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of immobilization-induced osteoporosis with human calcitonin].
    Nogarin L; Magnan B; Boscaro C; Lazzaretto R; Ambroso B
    G Clin Med; 1987 Jan; 68(1):17-20. PubMed ID: 3609593
    [No Abstract]   [Full Text] [Related]  

  • 24. [Long-term results of the treatment of postmenopausic osteoporosis with calcitonin and calcium].
    Rico Lenza H; Hernández Díez ER; Núñez-Torrón M; Torrubiano Aranguren J; Espinós Pérez D
    Med Clin (Barc); 1985 Apr; 84(14):563-5. PubMed ID: 3999833
    [No Abstract]   [Full Text] [Related]  

  • 25. What is new in the treatment of steroid-induced osteoporosis?
    Liu RH; Werth VP
    Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transient regional osteoporosis: an enigmatic disease with a good response to calcitonin].
    Nos C Fernández JM; Díaz P; Alvarez J
    Rev Neurol; 1995; 23(119):183-4. PubMed ID: 8548620
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnosis and treatment of osteoporosis].
    Reutter FW
    Minerva Med; 1974 Dec; 65(91):4836-43. PubMed ID: 4449613
    [No Abstract]   [Full Text] [Related]  

  • 28. [Efficacy of calcitonin in the symptomatic control of chronic backache due to senile osteoporosis].
    Gnudi S; Maggi G; Figus E; Rimondi E; Olmi R; Vellani G; Busacchi CA
    Clin Ter; 1986 Jul; 118(2):119-24. PubMed ID: 2943550
    [No Abstract]   [Full Text] [Related]  

  • 29. [The role of thyrocalcitonin in age induced osteoporosis].
    Vasiukova EA; Kochergina II
    Klin Med (Mosk); 1971 Sep; 49(9):101-4. PubMed ID: 5112684
    [No Abstract]   [Full Text] [Related]  

  • 30. [Calcitonin: nature, secretion mechanisms, therapeutic possibilities].
    Franchimont P; Heynen G; Reginster M; Denis F
    Brux Med; 1973 Dec; 53(12):719-27. PubMed ID: 4360270
    [No Abstract]   [Full Text] [Related]  

  • 31. [Behavior of urinary excretion of cyclic AMP in post-menopausal osteoporosis during therapy with salmon calcitonin].
    Nuti R; Galli M; Righi GA; Turchetti V; Campagna MS; Franci B
    Minerva Med; 1982 May; 73(19):1283-9. PubMed ID: 6281691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Our experience on the use of low-dose calcitonin in osteoporosis].
    Grecomoro G; Martorana U; Muscolino A
    Clin Ter; 1983 Nov; 107(4):297-303. PubMed ID: 6230203
    [No Abstract]   [Full Text] [Related]  

  • 33. [Osteoporosis: which prophylaxis and therapy?].
    Heinzl S
    Med Monatsschr Pharm; 2001 Sep; 24(9):281. PubMed ID: 11584759
    [No Abstract]   [Full Text] [Related]  

  • 34. [Value of principle component analysis in the study of therapeutic agents. Application in long-term treatment of osteoporosis using low calcitonin dosage].
    Milhaud G; Talbot JN; Coutris G
    Therapie; 1974; 29(4):611-8. PubMed ID: 4216112
    [No Abstract]   [Full Text] [Related]  

  • 35. [Calcitonin in the osteoporosis of rheumatic disease. Preliminary physiopathologic and clinical aspects and evaluation].
    Consoli G; Di Matteo L; Bosica D; D'Incecco V; Di Mascio C
    Clin Ter; 1986 Jul; 118(1):37-47. PubMed ID: 3742974
    [No Abstract]   [Full Text] [Related]  

  • 36. [First experience with the use of calcitonin].
    Kubović J
    Reumatizam; 1980; 27(2):46-7. PubMed ID: 7403710
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug therapy of osteoporosis].
    Dambacher MA
    Orthopade; 1988 Sep; 17(5):425-31. PubMed ID: 3054714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Improvement of QOL in osteoporotic patients by calcitonin treatment].
    Tanaka K; Yoshizawa M; Yoh K
    Clin Calcium; 2005 Mar; 15(3):174-8. PubMed ID: 15741699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of postmenopausal and senile osteoporosis with synthetic salmon calcitonin. A clinical study].
    Salvini S; Nicolazzo F; Farina P; Martelli G
    Clin Ter; 1987 Jun; 121(6):471-7. PubMed ID: 2973883
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of glucocorticoid osteoporosis (part II)].
    Nasonov EL; Skripnikova IA
    Klin Med (Mosk); 1997; 75(11):14-9. PubMed ID: 9490349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.